SCHEDULE OF BUSINESS SEGMENTS INFORMATION (Details) - USD ($)	3 Months Ended		9 Months Ended
	Sep. 30, 2024	Sep. 30, 2023	Sep. 30, 2024	Sep. 30, 2023	Dec. 31, 2023
Segment Reporting Information [Line Items]
Revenue	$ 390,852	$ 308,593	$ 1,134,098	$ 1,152,355
Gross Profit	354,056	276,259	1,025,133	1,049,425
Operating Income (Loss)	(35,135)	(25,481)	(28,489)	104,247
Total Assets	1,074,604		1,074,604		$ 992,298
Discontinued Operations [Member]
Segment Reporting Information [Line Items]
Total Assets	970		970		739
Vycor Medical [Member]
Segment Reporting Information [Line Items]
Revenue	372,837	287,559	1,078,644	1,087,758
Gross Profit	337,404	256,435	973,443	989,288
Operating Income (Loss)	52,688	60,373	223,061	366,360
Total Assets	1,028,839		1,028,839		957,936
NovaVision [Member]
Segment Reporting Information [Line Items]
Revenue	18,015	21,034	55,454	64,597
Gross Profit	16,652	19,824	51,690	60,137
Operating Income (Loss)	(43,215)	(41,868)	(127,783)	(146,592)
Total Assets	44,795		44,795		$ 33,623
Corporate Segment [Member]
Segment Reporting Information [Line Items]
Operating Income (Loss)	$ (44,608)	$ (43,986)	$ (123,767)	$ (115,521)